Copyright Reports & Markets. All rights reserved.

Global Doripenem Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Doripenem Market Overview

    • 1.1 Product Overview and Scope of Doripenem
    • 1.2 Classification of Doripenem by Types
      • 1.2.1 Global Doripenem Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Doripenem Revenue Market Share by Types in 2018
      • 1.2.3 500 mg single-use vial
      • 1.2.4 250 mg single-use vial
    • 1.3 Global Doripenem Market by Application
      • 1.3.1 Global Doripenem Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital
      • 1.3.3 Drug store
    • 1.4 Global Doripenem Market by Regions
      • 1.4.1 Global Doripenem Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Doripenem Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Doripenem Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Doripenem Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Doripenem Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Doripenem Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Doripenem (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Janssen
      • 2.1.1 Business Overview
      • 2.1.2 Doripenem Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Janssen Doripenem Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Shionogi
      • 2.2.1 Business Overview
      • 2.2.2 Doripenem Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Shionogi Doripenem Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Apotex
      • 2.3.1 Business Overview
      • 2.3.2 Doripenem Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Apotex Doripenem Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Doripenem Market Competition, by Players

    • 3.1 Global Doripenem Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Doripenem Players Market Share
      • 3.2.2 Top 10 Doripenem Players Market Share
    • 3.3 Market Competition Trend

    4 Global Doripenem Market Size by Regions

    • 4.1 Global Doripenem Revenue and Market Share by Regions
    • 4.2 North America Doripenem Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Doripenem Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Doripenem Revenue and Growth Rate (2014-2019)
    • 4.5 South America Doripenem Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Doripenem Revenue and Growth Rate (2014-2019)

    5 North America Doripenem Revenue by Countries

    • 5.1 North America Doripenem Revenue by Countries (2014-2019)
    • 5.2 USA Doripenem Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Doripenem Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Doripenem Revenue and Growth Rate (2014-2019)

    6 Europe Doripenem Revenue by Countries

    • 6.1 Europe Doripenem Revenue by Countries (2014-2019)
    • 6.2 Germany Doripenem Revenue and Growth Rate (2014-2019)
    • 6.3 UK Doripenem Revenue and Growth Rate (2014-2019)
    • 6.4 France Doripenem Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Doripenem Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Doripenem Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Doripenem Revenue by Countries

    • 7.1 Asia-Pacific Doripenem Revenue by Countries (2014-2019)
    • 7.2 China Doripenem Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Doripenem Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Doripenem Revenue and Growth Rate (2014-2019)
    • 7.5 India Doripenem Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Doripenem Revenue and Growth Rate (2014-2019)

    8 South America Doripenem Revenue by Countries

    • 8.1 South America Doripenem Revenue by Countries (2014-2019)
    • 8.2 Brazil Doripenem Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Doripenem Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Doripenem Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Doripenem by Countries

    • 9.1 Middle East and Africa Doripenem Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Doripenem Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Doripenem Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Doripenem Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Doripenem Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Doripenem Revenue and Growth Rate (2014-2019)

    10 Global Doripenem Market Segment by Type

    • 10.1 Global Doripenem Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Doripenem Market Forecast by Type (2019-2024)
    • 10.3 500 mg single-use vial Revenue Growth Rate (2014-2024)
    • 10.4 250 mg single-use vial Revenue Growth Rate (2014-2024)

    11 Global Doripenem Market Segment by Application

    • 11.1 Global Doripenem Revenue Market Share by Application (2014-2019)
    • 11.2 Doripenem Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Drug store Revenue Growth (2014-2019)

    12 Global Doripenem Market Size Forecast (2019-2024)

    • 12.1 Global Doripenem Market Size Forecast (2019-2024)
    • 12.2 Global Doripenem Market Forecast by Regions (2019-2024)
    • 12.3 North America Doripenem Revenue Market Forecast (2019-2024)
    • 12.4 Europe Doripenem Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Doripenem Revenue Market Forecast (2019-2024)
    • 12.6 South America Doripenem Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Doripenem Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. The usual form is doripenem monohydrate.

      Scope of the Report:
      The global Doripenem market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Doripenem.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Doripenem market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Doripenem market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Janssen
      Shionogi
      Apotex

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      500 mg single-use vial
      250 mg single-use vial

      Market Segment by Applications, can be divided into
      Hospital
      Drug store

      Buy now